Searching for pharmacogenomic markers: The synergy between omic and hypothesis-driven research

Disease Markers

Volumn 17, Issue 2, 2001, Pages 77-88

  Weinstein, J N ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cancer; Cancer therapy; Cell line; Clustered image map; Genomics; MedMiner; Microarray; Molecular marker; Omics; Pharmacogenomics; Pharmacology; Proteomics

Indexed keywords

ASPARAGINASE; ASPARTATE AMMONIA LIGASE; CHEMICAL COMPOUND; DIHYDROPYRIMIDINE DEHYDROGENASE; DNA; FLUOROURACIL; PROTEIN; RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANALYTIC METHOD; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER THERAPY; COLORECTAL CARCINOMA; DRUG DESIGN; DRUG RESEARCH; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HYPOTHESIS; IMAGING; MARKER GENE; MEDICAL LITERATURE; MOLECULAR INTERACTION; OVARY CARCINOMA; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RESEARCH;

EID: 0034794377     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/435746     Document Type: Article

References (42)

1. Molecular targets in cancer drug discovery: Cell-based profiling
2. Fishing Expeditions
3. Pharmacogenomics: Teaching old drugs new tricks
4. The future of new drug development
5. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen
6. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay
7. Feasibility of a high flux anticancer drug screen using a diverse panel of cultured human tumor cell lines
8. The National Cancer Institute: Cancer drug discovery and development program
9. Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen
10. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: Development of mean graph and COMPARE algorithm
11. Prediction of biochemical mechanism of action from the in vitro antitumor screen of the National Cancer Institute
12. Neural computing in cancer drug development: Predicting mechanism of action
13. Predictive statistics and artificial intelligence in the US National Cancer Institute's drug discovery program for cancer and AIDS
14. An information-intensive approach to the molecular pharmacology of cancer
15. Mapping genomic library clones using oligonucleotide arrays
16. Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data
17. Cell line-based screening for new anticancer drugs
18. Discrimination techniques applied to the NCI in vitro antitumor drug screen: Predicting biochemical mechanism of action
19. Application of genetic function approximation to the QSAR study of anticancer ellipticine analogs
20. Mining the National Cancer Institute's anticancer drug screen database: Cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity
21. Mining the NCI anticancer drug discovery databases: Genetic function approximation for the quantitative structure-activity relationship study of anticancer ellipticine analogs
22. Use of the Kohonen self-organizing map to study the mechanisms of action of chemotherapeutic agents
23. Neural network techniques for the informatics of cancer drug discovery
24. Molecular targets in the National Cancer Institute drug screen
25. National Cancer Institute drug information system 3D database
26. A protein expression database for the molecular pharmacology of cancer
27. Global approaches to quantitative analysis of gene-expression patterns observed by use of two-dimensional gel electrophoresis
28. Twenty years of two-dimensional electrophoresis: Past, present and future
29. Rapid protein identification from two-dimensional polyacrylamide gels by MALDI mass spectrometry
30. Systematic variation in gene expression patterns in human cancer cell lines
31. A gene expression database for the molecular pharmacology of cancer
32. Chemosensitivity prediction by transcriptional profiling
33. Cluster analysis and display of genome-wide expression patterns
34. Cluster analysis of molecular conformations
35. A leisurely look at the bootstrap, the jackknife, and cross-validation
36. New opportunities for uncovering the molecular basis of cancer
37. The cancer genome anatomy project: Building a new information and technology platform for cancer research
38. MedMiner: An internet tool for mining information, with application to gene expression profiling
39. EDGAR: Drugs, genes and relations from the biomedical literature
40. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: Microarray analysis of dose- and time-dependent effects